Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Gut-Brain Axis01:22

Gut-Brain Axis

53
The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such...
53
Long-term Depression01:03

Long-term Depression

3.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
3.6K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dopaminergic vulnerability in long COVID: striatal PET imaging at the brain-body interface.

EBioMedicine·2026
Same author

Correction: Plasma Aβ42/p-Tau217 ratio and p-Tau217 independently predict CSF-defined Alzheimer's disease pathology in a Brazilian admixed cohort.

Frontiers in aging neuroscience·2026
Same author

Irisin promotes selective changes in hippocampal mitochondrial metabolism in mice.

Biochemistry and biophysics reports·2026
Same author

Plasma Aβ42/p-Tau217 ratio and p-Tau217 independently predict CSF-defined Alzheimer's disease pathology in a Brazilian admixed cohort.

Frontiers in aging neuroscience·2026
Same author

Current status and future perspectives on the mechanistic and pathophysiological understanding of long COVID.

Communications medicine·2026
Same author

Loss of neuronal population organization links pathology to behavior in a model of Alzheimer's disease.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Mar 29, 2026

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques
10:52

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques

Published on: June 1, 2016

12.1K

Microglial dysfunction connects depression and Alzheimer's disease.

Luís Eduardo Santos1, Danielle Beckman2, Sergio T Ferreira3

  • 1Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro, RJ 21944-590, Brazil.

Brain, Behavior, and Immunity
|November 28, 2015
PubMed
Summary

Microglia-driven neuroinflammation links Alzheimer's disease (AD) and major depressive disorder (MDD). Targeting these brain immune cells may offer a unified treatment strategy for both conditions.

Keywords:
Alzheimer’s diseaseMajor depressive disorderMicrogliaNeuroinflammation

More Related Videos

Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain
10:40

Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain

Published on: October 27, 2019

35.7K
Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
04:22

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Published on: May 20, 2024

1.5K

Related Experiment Videos

Last Updated: Mar 29, 2026

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques
10:52

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques

Published on: June 1, 2016

12.1K
Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain
10:40

Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain

Published on: October 27, 2019

35.7K
Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
04:22

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Published on: May 20, 2024

1.5K

Area of Science:

  • Neuroscience
  • Immunology
  • Psychiatry

Background:

  • Alzheimer's disease (AD) and major depressive disorder (MDD) share epidemiological links and involve neuroinflammation.
  • Microglia, the brain's immune cells, play a central role in neuroinflammation, impacting both AD and MDD pathology.
  • Dysfunctional microglia are implicated in synaptic and neurogenesis deficits seen in these disorders.

Purpose of the Study:

  • To review current findings on the inflammatory hypotheses of AD and MDD.
  • To highlight the role of microglia as a common link between AD and MDD.
  • To explore microglia as a potential therapeutic target for both conditions.

Main Methods:

  • Review of recent scientific literature on neuroinflammation, microglia, AD, and MDD.
  • Analysis of studies investigating cytokine production and microglial activation in relation to AD and MDD.
  • Examination of the link between amyloid-beta (Aβ) oligomers, neuroinflammation, and depressive behaviors.

Main Results:

  • Microglia-derived cytokines can induce depressive-like symptoms.
  • MDD patients exhibit elevated pro-inflammatory cytokine levels, suggesting inflammation's role in depression.
  • Activated microglia cluster around amyloid plaques in AD brains, influencing Aβ burden and disease progression.
  • Soluble Aβ oligomers are linked to increased cytokine production and depressive behaviors in preclinical models.

Conclusions:

  • Neuroinflammation, mediated by microglia, is a significant factor in both AD and MDD.
  • Microglia represent a promising common therapeutic target for treating AD and MDD concurrently.
  • Further research into microglial function could lead to novel treatment strategies for these prevalent neuropsychiatric disorders.